A Phase 2 Study of Ruxolitinib with Chemotherapy in Children with Philadelphia Chromosome-like Acute Lymphoblastic Leukemia (AALL1521/INCB18424-269): Biologic Characteristics and Minimal Residual Disease Response of Patients with Non-CRLF2-Rearranged JAK Pathway Alterations

Authors :: Sarah K Tasian
Deborah S Hunter
I-Ming L Chen
Richard C Harvey
Andrew J. Carroll
Elizabeth Wagner
Shalini C Reshmi
Michael J Borowitz
Brent L. Wood
Jeannie Daniel
Meenakshi Devidas
Elizabeth A. Raetz
Stephen P. Hunger
Albert Assad
Mignon L. Loh
Source :: Blood. 140:6117-6118
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools